Afuco™ Anti-Human CSF1 ADCC Therapeutic Antibody (PD-0360324), ADCC Enhanced
Anti-CSF1 ADCC Enhanced Antibody (PD-0360324) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a novel neutralizing human monoclonal antibody against monocyte/ macrophage colony stimulating factor (M-CSF). It exhibited a nonlinear PK profile associated with rapid suppression of PD markers and was generally well tolerated. The safety and efficacy profile will be investigated further in a multi-dose study in patients with rheumatoid arthritis.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-177CL |
| Pricing | Inquiry |
| Host | Human |
| Target | CSF1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage |
|